Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,522Revenue (TTM) $M30.6Net Margin (%)-685.9Altman Z-Score6.2
Enterprise Value $M1,292EPS (TTM) $-0.8Operating Margin %-680.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-685.9Higher ROA y-yN
Price/Book8.310-y EBITDA Growth Rate %2.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales40.55-y EBITDA Growth Rate %17.2Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-46.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-64.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M271ROIC % (ttm)-155.5Gross Margin Increase y-yY

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXGeorge Soros 2016-03-31 Buy $4.36 - $8.39
($5.42)
$ 5.624%New holding30,300
NVAXJoel Greenblatt 2015-12-31 Sold Out -0.01%$6.59 - $8.77
($7.73)
$ 5.62-27%Sold Out0
NVAXJoel Greenblatt 2015-09-30 Buy 0.01%$6.41 - $14.14
($11.21)
$ 5.62-50%New holding110,640
NVAXFirst Eagle Investment 2014-12-31 Sold Out -0.0052%$4.05 - $5.98
($5.25)
$ 5.627%Sold Out0
NVAXFirst Eagle Investment 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 5.6228%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
($5.59)
$ 5.621%Sold Out0
NVAXFirst Eagle Investment 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 5.621%Reduce -75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
($3.51)
$ 5.6260%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 5.6260%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 5.6299%New holding573,000
NVAXFirst Eagle Investment 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 5.6299%New holding800,000
NVAXFirst Eagle Investment 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 5.62130%Sold Out0
NVAXFirst Eagle Investment 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 5.62155%Add 25.00%125,000
NVAXFirst Eagle Investment 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 5.62128%Reduce -52.65%100,000
NVAXFirst Eagle Investment 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 5.6262%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EVANS GARY CDirector 2016-05-24Sell50,000$5.414.81view
Erck Stanley CPresident and CEO 2016-03-31Sell424,778$5.199.25view
Trizzino JohnSVP, Commercial Operations 2016-01-31Buy5,855$3.6356.2view
Herrmann John A IIISVP, General Counsel 2016-01-31Buy2,072$4.3829.45view
Glenn Gregory MSVP, Research and Development 2016-01-31Buy2,369$4.3829.45view
PHILLIPS BARCLAY ASVP, CFO 2016-01-31Buy405$4.3829.45view
Erck Stanley CCEO and President 2016-01-31Buy2,072$4.3829.45view
Glenn Gregory MSVP, Research and Development 2015-12-16Sell61,886$8.58-33.92view
Herrmann John A IIISVP, General Counsel 2015-12-16Sell27,945$8.64-34.38view
EVANS GARY CDirector 2015-08-24Sell20,000$11.24-49.56view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
Why Novavax, Inc. (NVAX)’s Shares Are Trading in Green on Wednesday? May 25 2016
Will Novavax pull back later this year? May 25 2016
U.S. FDA Grants Fast Track Designation to Novavax’ RSV F Vaccine for Older Adults - May 25 2016
U.S. FDA Grants Fast Track Designation to Novavax' RSV F Vaccine for Older Adults - May 25 2016
8:01 am Novavax announces that the FDA has granted Fast Track Designation to its' RSV F-Protein... May 25 2016
U.S. FDA Grants Fast Track Designation to Novavax’ RSV F Vaccine for Older Adults May 25 2016
ETF’s with exposure to Novavax, Inc. : May 24, 2016 May 24 2016
[$$] Four Biotech Picks With 2016 Catalysts May 23 2016
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : May 23, 2016 May 23 2016
NOVAVAX INC Financials May 12 2016
Novavax Receives the Tech Council of Maryland’s Chairman’s Award - May 12 2016
Novavax Receives the Tech Council of Maryland's Chairman's Award - May 12 2016
Novavax Receives the Tech Council of Maryland’s Chairman’s Award May 12 2016
Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day - May 11 2016
Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day May 11 2016
Novavax, Inc. :NVAX-US: Earnings Analysis: Q1, 2016 By the Numbers May 10 2016
Edited Transcript of NVAX earnings conference call or presentation 4-May-16 8:30pm GMT May 05 2016
ETF’s with exposure to Novavax, Inc. : May 5, 2016 May 05 2016
NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)